April 29, 2015
April 29, 2015 —
…cells it activates — to destroy prostate tumors. This novel combination therapy, termed chemoimmunotherapy, achieved near complete remission in mouse models of advanced prostate cancer. The study is published April 29 in Nature.
March 1, 2012
March 1, 2012 —
UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego Company, Tocagen Inc.
March 2, 2021
March 2, 2021 —
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.
March 6, 2013
March 6, 2013 —
…Research Institute. These singular enterprises have now formed a novel collaboration to leverage their distinct and combined resources and talents.
December 15, 2015
December 15, 2015 —
…at protecting older individuals. More broadly, the findings reveal novel molecular signatures that could be used to predict which individuals are most likely to respond positively to vaccination.
August 11, 2015
August 11, 2015 —
…and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer. The agent, named SF1126, acts by inhibiting the part of the cancer cell engine that promotes tumor angiogenesis and growth.
October 9, 2024
October 9, 2024 —
El Centro Mayor, Sylvia Marroquin, shares her journey with kidney cancer and how a clinical trial at UC San Diego Health saved her life.
May 16, 2022
May 16, 2022 —
COVID-19, MIS-C and KD all share a similar underlying mechanism involving the over-activation of particular inflammatory pathways, UC San Diego study shows. Findings support novel drug targets for MIS-C.
March 9, 2018
March 9, 2018 —
…effectiveness of a standard of care drug with a novel monoclonal antibody that target B-cell malignancies, which include leukemias and lymphomas.
May 17, 2017
May 17, 2017 —
Chemists, materials scientists and nanoengineers at UC San Diego have created what may be the ultimate natural sunscreen. In a paper published in the American Chemical Society journal ACS Central Science, they report the development of nanoparticles that mimic the behavior of natural melanosomes, melanin-producing cell structures that protect our…